We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Public Health

Public Health

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Beyond the Lungs: How Ambient Air Pollution Drives Alzheimer’s Neuropathology and Cognitive Decline
NeurologyAlzheimer's diseaseNeuroimaging

Beyond the Lungs: How Ambient Air Pollution Drives Alzheimer’s Neuropathology and Cognitive Decline

By MedXY|Jan 2, 2026

Emerging evidence confirms that air pollution, particularly PM2.5 and NO2, is directly associated with Alzheimer’s neuropathology, structural brain changes, and cognitive decline. New research highlights that these effects are partially med

Durability and Decay: Evaluating Long-term RSV Vaccine Effectiveness in a Large Real-World Cohort of US Veterans
Clinical Updatesgeriatric medicineimmunocompromised

Durability and Decay: Evaluating Long-term RSV Vaccine Effectiveness in a Large Real-World Cohort of US Veterans

By MedXY|Jan 2, 2026

This review analyzes the long-term effectiveness of RSV vaccination among US Veterans, revealing significant protection against severe outcomes that wanes over two seasons, particularly in immunocompromised populations.

Narrowing the Equity Gap: The Impact of California’s 2022 Medicaid Expansion on Access to SGLT-2 Inhibitors and GLP-1 RAs in Older Undocumented Immigrants
Clinical Updateshealth equityMở rộng Medicaid

Narrowing the Equity Gap: The Impact of California’s 2022 Medicaid Expansion on Access to SGLT-2 Inhibitors and GLP-1 RAs in Older Undocumented Immigrants

By MedXY|Dec 31, 2025

This review analyzes the significant shift in type 2 diabetes prescribing patterns following California’s 2022 Medi-Cal expansion, highlighting how policy-driven access to SGLT-2 inhibitors and GLP-1 receptor agonists narrowed health

Can Sertraline Reduce Repeat Violent Offenses? Insights from a Major Clinical Trial
newsclinical trialmental health

Can Sertraline Reduce Repeat Violent Offenses? Insights from a Major Clinical Trial

By MedXY|Dec 29, 2025

A large, rigorous study found that sertraline, an antidepressant, does not significantly lower the risk of repeated violent crimes among impulsive offenders.

Comprehensive Review of Digital Nudges to Enhance Influenza Vaccination Uptake in Chronic and Cardiovascular Disease Patients
Cardiologycardiovascular diseasechronic disease

Comprehensive Review of Digital Nudges to Enhance Influenza Vaccination Uptake in Chronic and Cardiovascular Disease Patients

By MedXY|Dec 28, 2025

Electronic behavioral nudges significantly improve influenza vaccination rates among patients with chronic and cardiovascular diseases, offering scalable public health strategies.

Preconception Trace Metal Profiles in Couples: A New Frontier in Optimizing IVF Embryological Outcomes
newsIVFreproductive health

Preconception Trace Metal Profiles in Couples: A New Frontier in Optimizing IVF Embryological Outcomes

By MedXY|Dec 27, 2025

A prospective study of 1071 couples identifies that plasma trace metal concentrations in both partners significantly influence IVF success, with elements like iron and molybdenum showing benefits while silver and thallium pose risks to embr

The Long Shadow of the ICU: Identifying High-Risk Functional Trajectories in Older Survivors
Critical Carecritical carefunctional recovery

The Long Shadow of the ICU: Identifying High-Risk Functional Trajectories in Older Survivors

By MedXY|Dec 26, 2025

A large-scale longitudinal study reveals that ICU survivors aged 60–79 face significantly higher 5-year excess mortality and functional decline compared to the general population, whereas outcomes for nonagenarians converge with their peers

Statin Initiation and Follow-Up Testing Are Declining in Young Adults Despite High Cardiovascular Risk
CardiologyDyslipidemiastatins

Statin Initiation and Follow-Up Testing Are Declining in Young Adults Despite High Cardiovascular Risk

By MedXY|Dec 25, 2025

A large-scale study of over 700,000 young adults reveals a concerning decline in lipid follow-up and statin initiation between 2008 and 2018, highlighting a critical care gap in preventing premature cardiovascular disease during a key windo

Benchmarking the Ovarian Reserve: New Population-Based Data Reveal Wide Variability in Young Women
newsreproductive health

Benchmarking the Ovarian Reserve: New Population-Based Data Reveal Wide Variability in Young Women

By MedXY|Dec 25, 2025

A Norwegian population-based study of 492 women aged 18-22 reveals significant inter-individual variability in ovarian volume, antral follicle count, and AMH levels, providing a critical baseline for understanding reproductive health before

High-Dose Influenza Vaccination Reduces Hospitalizations and Cardiovascular Events in Older Adults: Insights from the FLUNITY-HD Pooled Analysis
Cardiologycardiovascular diseasegeriatric medicine

High-Dose Influenza Vaccination Reduces Hospitalizations and Cardiovascular Events in Older Adults: Insights from the FLUNITY-HD Pooled Analysis

By MedXY|Dec 25, 2025

The FLUNITY-HD pooled analysis of over 466,000 older adults demonstrates that high-dose inactivated influenza vaccine (HD-IIV) significantly reduces hospitalizations for influenza, pneumonia, and cardiovascular causes, including a 21.3% red

Beyond the Lead Apron: New Evidence of High Orthopedic and Reproductive Risks in Cardiac Electrophysiology
CardiologyElectrophysiologyoccupational health

Beyond the Lead Apron: New Evidence of High Orthopedic and Reproductive Risks in Cardiac Electrophysiology

By MedXY|Dec 25, 2025

A global Heart Rhythm Society survey reveals that 41% of EP professionals suffer from orthopedic injuries and 50% of women face pregnancy complications, highlighting the urgent need for systemic improvements in laboratory ergonomics and rad

Beyond Patient Factors: Modifying Surgical Practice to Mitigate Racial Disparities in Benign Hysterectomy
newsChất lượng phẫu thuậthealth equity

Beyond Patient Factors: Modifying Surgical Practice to Mitigate Racial Disparities in Benign Hysterectomy

By MedXY|Dec 24, 2025

This study identifies key modifiable surgical and hospital-level factors—including surgical approach and antibiotic adherence—that contribute to the disproportionately higher rate of postoperative complications experienced by Black patients

Efficacy of mHealth Interventions for Smoking Cessation in Tuberculosis Patients: Insights from a Cluster Randomized Clinical Trial
AIclinical trialmHealth

Efficacy of mHealth Interventions for Smoking Cessation in Tuberculosis Patients: Insights from a Cluster Randomized Clinical Trial

By MedXY|Dec 24, 2025

An mHealth text messaging intervention significantly improves smoking cessation rates and reduces mortality among TB patients compared to usual care, supporting its implementation in TB programs.

FDA Modernization Act 3.0: A Legislative Catalyst for the Post-Animal Testing Era in Clinical Pharmacology
newsDrug Development

FDA Modernization Act 3.0: A Legislative Catalyst for the Post-Animal Testing Era in Clinical Pharmacology

By MedXY|Dec 23, 2025

The U.S. Senate’s unanimous passage of the FDA Modernization Act 3.0 marks a definitive shift in drug regulation, formally replacing ‘animal’ mandates with ‘nonclinical’ methodologies like organ-on-a-chip and A

Occupation Matters: New Data Reveal Wide Disparities in US Cancer Mortality Among Working-Age Adults
newshealth equityoccupational health

Occupation Matters: New Data Reveal Wide Disparities in US Cancer Mortality Among Working-Age Adults

By MedXY|Dec 23, 2025

A comprehensive population study of 450,453 deaths identifies specific occupations, including fishing, mining, and funeral services, with disproportionately high cancer mortality, suggesting a complex interplay of workplace exposures and st

Benchmarking Global Progress in Non-Communicable Diseases: A Comprehensive Analysis of Cause-Specific Mortality Trends from 2001 to 2019
Clinical Updatesepidemiologyglobal health

Benchmarking Global Progress in Non-Communicable Diseases: A Comprehensive Analysis of Cause-Specific Mortality Trends from 2001 to 2019

By MedXY|Dec 23, 2025

From 2010 to 2019, NCD mortality declined in 80% of countries worldwide, driven primarily by reductions in circulatory diseases, with notable regional and cause-specific heterogeneity and slower progress than the previous decade.

Individualized Feedback Letters Fail to Reduce Long-Term Alcohol Consumption: Insights from a 4-Year RCT
newsdigital healthpublic health

Individualized Feedback Letters Fail to Reduce Long-Term Alcohol Consumption: Insights from a 4-Year RCT

By MedXY|Dec 23, 2025

A 4-year randomized controlled trial found that computer-generated feedback letters failed to reduce alcohol consumption in the general population. Unexpectedly, the control group showed greater reduction at 48 months, suggesting that curre

Optimizing Opioid Use Disorder Treatment: When Does 300 mg Outperform 100 mg of Extended-Release Buprenorphine?
newsbuprenorphinefentanyl

Optimizing Opioid Use Disorder Treatment: When Does 300 mg Outperform 100 mg of Extended-Release Buprenorphine?

By MedXY|Dec 21, 2025

This randomized clinical trial compares 100-mg and 300-mg maintenance doses of extended-release buprenorphine. While overall efficacy was similar, the 300-mg dose significantly improved abstinence among patients with high-frequency fentanyl

Beyond the Common Cold: Deciphering the Surge of Influenza Subclade K Across Europe
Infectious Diseasesinfluenzapublic health

Beyond the Common Cold: Deciphering the Surge of Influenza Subclade K Across Europe

By MedXY|Dec 20, 2025

A new influenza strain, Subclade K (AH3N2 J.2.4.1), is dominating Europe’s flu season with a 90% prevalence rate. Experts emphasize that while the strain is highly transmissible, vaccination remains the most effective tool for prevent

High-Dose Extended-Release Buprenorphine: A Targeted Strategy for the Fentanyl-Driven Opioid Crisis
newsbuprenorphinefentanyl

High-Dose Extended-Release Buprenorphine: A Targeted Strategy for the Fentanyl-Driven Opioid Crisis

By MedXY|Dec 20, 2025

This randomized clinical trial compares 100-mg versus 300-mg maintenance doses of extended-release buprenorphine. While overall efficacy was similar, the 300-mg dose significantly improved abstinence rates among heavy fentanyl users, offeri

Prev
17 / 25
1…1516171819…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles